arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

McKesson Corporation

MCK Health Care Other Pharmaceuticals
$1,012.34
▼ -1.7% Today
as of Oct 22, 16:50 ET
Last 30 days +11.13% Sep 14 → Oct 22
$839.71 $890.84 $941.96 $993.09 $1044.22 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$1,025.62
High
$1,025.00
Low
$1,006.07
Volume
$629,436
Avg Vol
$889,751
Mkt Cap
$106.1B
P/E (TTM)
42.47
Beta
—
52w High
$1,030.27
52w Low
$723.68
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 1 ● 24 ▼ 0
Oct 21 · 20:50 Zacks neutral
McKesson (MCK) Stock Dips While Market Gains: Key Facts
Oct 21 · 12:00 RATING Zacks neutral
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Oct 21 · 12:00 PR Business Wire neutral
McKesson Corporation Declares Quarterly Dividend
▸ Show all 25 press releases & news Free account →

MCK earnings at a glance

McKesson Corporation (MCK) is scheduled to report earnings on Wednesday, November 4, 2026 after the market closes — in 12 days. Analysts expect earnings per share of $10.72, compared with $9.86 in the same quarter last year (+9%). The options market is pricing a move of about ±3.1% after the report, a range of roughly $980.89 to $1,043.79 from today's $1,012.34. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±4.6% on average; after the most recent report on Aug 5, 2026 it moved -0.7%. That means options currently expect less movement than MCK has typically delivered. MCK beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 26%. The share price of $1,012.34 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$724
$1.0K
94% of range
Avg surprise (last 6)
+3.4%
Avg reaction (last 6)
+1.6%
50% positive
Latest IV / EM
26%
EM ±3.1% · $930 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.87$4.33$6.78$9.23$11.69 Actual $4.92Actual $4.42Actual $7.00Actual $1.87Actual $6.95Actual $10.12Est $9.81Actual $8.26Est $8.23Actual $9.86Est $8.92Actual $9.59Actual $9.34Est $9.31Actual $11.69Est $11.56Actual $9.93Est $9.44 SepDecJunSepDecMar/2025Jun/2025Sep/2025Dec8KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$0$27.9B$55.7B$83.6B$111.5B Sep 24Dec 24Jun 25Sep 25Dec 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 5, 2026Jun/2026 $9.93 $9.44 +5.2% +14.3% -0.7% earnings
Thu May 7, 2026Mar/2026 $11.69 $11.56 +1.1% +15.5% -2.5% earnings
Wed Feb 4, 20268K 2026-02-04 $9.34 $9.31 +0.3% — +16.5% earnings
Wed Dec 31, 2025Dec 2025 $9.59 — — — — financials
Wed Nov 5, 2025Sep/2025 $9.86 $8.92 +10.5% — +1.7% earnings
Wed Aug 6, 2025Jun/2025 $8.26 $8.23 +0.4% — -5.8% earnings
Thu May 8, 2025Mar/2025 $10.12 $9.81 +3.2% — +0.5% earnings
Tue Dec 31, 2024Dec 2024 $6.95 — — — — financials
Mon Sep 30, 2024Sep 2024 $1.87 — — — — financials
Sun Jun 30, 2024Jun 2024 $7.00 — — — — financials
Sun Dec 31, 2023Dec 2023 $4.42 — — — — financials
Sat Sep 30, 2023Sep 2023 $4.92 — — — — financials
Fri Jun 30, 2023Jun 2023 $7.02 — — — — financials
Sat Dec 31, 2022Dec 2022 $7.66 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026AMC $10.72$9.86 +8.7%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$105.38B—$106.16B$103.15B$97.83B—$95.29B$93.65B
Cost of revenue$101.69B—$102.47B$99.61B$94.55B—$92.01B$90.40B
Gross profit$3.69B—$3.69B$3.54B$3.28B—$3.28B$3.25B
Operating income$1.32B—$1.62B$1.41B$1.04B—$1.22B$578M
Net income$614M—$1.19B$1.11B$784M—$879M$241M
EPS (diluted)$5.15—$9.59$8.92$6.25—$6.95$1.87

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$5.16B$3.98B$2.96B$4.00B$2.42B$5.69B$1.13B$2.51B
Inventory$26.26B$24.21B$27.07B$26.13B$25.07B$23.00B$23.84B$24.18B
Total current assets$62.84B$57.21B$59.70B$59.89B$56.80B$55.40B$51.74B$53.34B
Total assets$88.33B$82.32B$84.19B$84.16B$81.31B$75.14B$71.08B$72.43B
Long-term debt$9.73B$6.53B$6.56B$7.76B$7.78B—$5.59B$5.74B
Total liabilities————————
Total equity$-4.24B$-2.17B$-1.30B$-1.35B$-1.59B$-2.07B$-2.70B$-2.64B

Implied volatility — last 90 days

22%28%34%39%45% Jun 07 — IV 30% · EM ±4.2%Jun 08 — IV 31% · EM ±4.0%Jun 09 — IV 31% · EM ±3.9%Jun 10 — IV 29% · EM ±3.4%Jun 11 — IV 30% · EM ±3.3%Jun 12 — IV 29% · EM ±3.0%Jun 15 — IV 32% · EM ±2.3%Jun 16 — IV 33% · EM ±1.9%Jun 17 — IV 36% · EM ±1.5%Jun 19 — IV 28% · EM ±6.2%Jun 22 — IV 29% · EM ±6.0%Jun 23 — IV 28% · EM ±5.8%Jun 24 — IV 27% · EM ±5.4%Jun 25 — IV 26% · EM ±5.2%Jun 26 — IV 26% · EM ±4.9%Jun 29 — IV 27% · EM ±4.8%Jun 30 — IV 27% · EM ±4.7%Jul 01 — IV 27% · EM ±4.4%Jul 02 — IV 25% · EM ±4.0%Jul 03 — IV 26% · EM ±4.0%Jul 06 — IV 29% · EM ±4.0%Jul 07 — IV 25% · EM ±3.3%Jul 08 — IV 29% · EM ±3.7%Jul 09 — IV 28% · EM ±3.3%Jul 10 — IV 26% · EM ±2.8%Jul 13 — IV 33% · EM ±2.8%Jul 14 — IV 31% · EM ±2.3%Jul 15 — IV 33% · EM ±1.9%Jul 16 — IV 36% · EM ±1.5%Jul 20 — IV 35% · EM ±8.4%Jul 21 — IV 36% · EM ±8.3%Jul 22 — IV 35% · EM ±8.1%Jul 23 — IV 36% · EM ±8.1%Jul 24 — IV 35% · EM ±7.8%Jul 27 — IV 37% · EM ±7.7%Jul 28 — IV 35% · EM ±7.2%Jul 29 — IV 36% · EM ±7.2%Jul 30 — IV 37% · EM ±7.3%Jul 31 — IV 37% · EM ±7.1%Aug 03 — IV 41% · EM ±7.3%Aug 04 — IV 43% · EM ±7.3%Aug 05 — IV 45% · EM ±7.6%Aug 06 — IV 29% · EM ±4.8%Aug 07 — IV 29% · EM ±4.5%Aug 10 — IV 28% · EM ±3.9%Aug 11 — IV 25% · EM ±3.3%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 33% · EM ±3.9%Aug 14 — IV 28% · EM ±3.1%Aug 17 — IV 35% · EM ±3.0%Aug 18 — IV 33% · EM ±2.4%Aug 19 — IV 33% · EM ±2.0%Aug 20 — IV 37% · EM ±1.5%Aug 24 — IV 26% · EM ±5.5%Aug 25 — IV 25% · EM ±5.1%Aug 26 — IV 25% · EM ±4.9%Aug 27 — IV 24% · EM ±4.8%Aug 28 — IV 24% · EM ±4.7%Aug 31 — IV 24% · EM ±4.3%Sep 01 — IV 24% · EM ±4.1%Sep 02 — IV 24% · EM ±4.0%Sep 03 — IV 23% · EM ±3.8%Sep 04 — IV 23% · EM ±3.7%Sep 07 — IV 26% · EM ±3.7%Sep 08 — IV 27% · EM ±3.6%Sep 09 — IV 25% · EM ±3.1%Sep 10 — IV 25% · EM ±3.0%Sep 11 — IV 23% · EM ±2.5%Sep 14 — IV 28% · EM ±2.3%Sep 15 — IV 32% · EM ±2.3%Sep 16 — IV 32% · EM ±1.9%Sep 17 — IV 26% · EM ±1.1%Sep 21 — IV 26% · EM ±5.3%Sep 22 — IV 25% · EM ±5.2%Sep 23 — IV 25% · EM ±5.1%Sep 24 — IV 26% · EM ±5.0%Sep 25 — IV 24% · EM ±4.6%Sep 28 — IV 26% · EM ±4.6%Sep 29 — IV 26% · EM ±4.5%Sep 30 — IV 27% · EM ±4.5%Oct 01 — IV 27% · EM ±4.4%Oct 02 — IV 25% · EM ±3.9%Oct 05 — IV 23% · EM ±3.2%Oct 06 — IV 26% · EM ±3.4%Oct 07 — IV 25% · EM ±3.2%Oct 08 — IV 26% · EM ±3.1%

Sector peers

COR
Cencora, Inc.
$60.5B $338.48-1.4%
CAH
Cardinal Health, Inc.
$53.8B $255.64-0.7%
HLF
Herbalife Ltd.
$1.3B $13.78+0.1%
NUS
Nu Skin Enterprises, Inc.
$234M $4.92-1.2%
HWH
HWH International Inc.
$69M $2.68+15.0%
COSM
Cosmos Health Inc.
$39M $0.25-23.6%

MCK earnings FAQ

When is MCK's next earnings date?

McKesson Corporation is expected to report on November 4, 2026, after the market closes.

What is MCK's expected move for earnings?

Options currently price a move of about ±3.1%, or $31.45 per share either way from $1,012.34.

How does MCK stock usually react to earnings?

Across the last 6 reports the average next-day move was ±4.6%, up 3 times and down 3 times.

What EPS are analysts expecting from McKesson Corporation?

The consensus estimate is $10.72 per share, versus $9.86 a year ago.

What is MCK's implied volatility?

MCK's at-the-money implied volatility is about 26% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in